A novel class of oral, non-immunosuppressive, beta cell-targeting, TXNIP-inhibiting T1D drugs is emerging

Diabetes treatment options have improved dramatically over the last 100 years, however, close to 2 million individuals in the U.S. alone live with type 1 diabetes (T1D) and are still dependent on multiple daily insulin injections and/or continuous insulin infusion with a pump to stay alive and no or...

Full description

Bibliographic Details
Published in:	Frontiers in Endocrinology
Main Authors:	Gu Jing, SeongHo Jo, Anath Shalev
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-10-01
Subjects:	TXNIP TIX100 verapamil islets diabetes oral medication
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2024.1476444/full

Similar Items

A novel application perspective of the clinical-used drug verapamil on osteoporosis via targeting Txnip
by: Xiankun Cao, et al.
Published: (2025-01-01)

Intra-arterial verapamil improves functional outcomes of thrombectomy in a preclinical model of extended hyperglycemic stroke
by: Sanaz Nasoohi, et al.
Published: (2023-04-01)

Signaling Pathway of Taurine-Induced Upregulation of TXNIP
by: Hideo Satsu, et al.
Published: (2022-07-01)

Genome editing of TXNIP in human pluripotent stem cells for the generation of hepatocyte-like cells and insulin-producing islet-like aggregates
by: Leonardo Traini, et al.
Published: (2025-05-01)

Trim21 deficiency alleviates osteoporosis by inhibiting osteoclast differentiation through regulating Txnip
by: Ya-Chen Peng, et al.
Published: (2025-08-01)

Suppression of pancreatic cancer proliferation through TXNIP-mediated inhibition of the MAPK signaling pathway
by: Fei Qinglin, et al.
Published: (2024-01-01)

TXNIP/TBP-2: A Master Regulator for Glucose Homeostasis
by: Eiji Yoshihara
Published: (2020-08-01)

High TXNIP expression accelerates the migration and invasion of the GDM placenta trophoblast
by: Rina Sa, et al.
Published: (2023-04-01)

PTBP1 knockdown impairs autophagy flux and inhibits gastric cancer progression through TXNIP-mediated oxidative stress
by: Shimin Wang, et al.
Published: (2024-08-01)

DPEP Inhibits Cancer Cell Glucose Uptake, Glycolysis and Survival by Upregulating Tumor Suppressor TXNIP
by: Qing Zhou, et al.
Published: (2024-06-01)

ITCH facilitates proteasomal degradation of TXNIP in hypoxia‐ induced lung cancer cells
by: Qian Sun, et al.
Published: (2022-08-01)

TXNIP induces growth arrest and enhances ABT263‐induced apoptosis in mixed‐lineage leukemia‐rearranged acute myeloid leukemia cells
by: Mina Noura, et al.
Published: (2020-08-01)

Thioredoxin-Interacting Protein (TXNIP) in Gestational Diabetes Mellitus
by: Ioanna Kokkinopoulou, et al.
Published: (2025-05-01)

Silencing hnRNPD inhibits gastric cancer growth by increasing TXNIP-mediated oxidative stress
by: Xuan Zou, et al.
Published: (2025-05-01)

Txnip deletions and missense alleles prolong the survival of cones in a retinitis pigmentosa mouse model
by: Yunlu Xue, et al.
Published: (2024-05-01)

New horizon of the combined BCG vaccine with probiotic and liraglutide in augmenting beta cell survival via suppression of TXNIP/NLRP3 pyroptosis signaling in Streptozocin–Induced diabetes mellitestype-1 in rats
by: Amira Karam Khalifa, et al.
Published: (2024-10-01)

TXNIP regulates pulmonary inflammation induced by Asian sand dust
by: So-Won Pak, et al.
Published: (2024-12-01)

The MondoA-dependent TXNIP/GDF15 axis predicts oxaliplatin response in colorectal adenocarcinomas
by: Jinhai Deng, et al.
Published: (2024-08-01)

Transcriptomic Analysis of the Effect of Metformin against Cisplatin-Induced Ototoxicity: A Potential Mechanism of Metformin-Mediated Inhibition of Thioredoxin-Interacting Protein (Txnip) Gene Expression
by: Sehee Lee, et al.
Published: (2022-12-01)

Increased level of TXNIP and nuclear translocation of TXN is associated with end stage renal disease and development of multiplex renal tumours
by: Tamas Beothe, et al.
Published: (2024-07-01)

Thioredoxin-1 inhibits NLRP3-mediated pyroptosis by regulating TXNIP in models of Alzheimer’s disease
by: Jinjing Jia, et al.
Published: (2025-05-01)

PIAS3 promotes ferroptosis by regulating TXNIP via TGF-β signaling pathway in hepatocellular carcinoma
by: Wenfang Bao, et al.
Published: (2023-10-01)

Hemodialysis Serum Stimulates the TXNIP-eNOS-STAT3 Inflammatory Pathway In Vitro
by: Keren Cohen-Hagai, et al.
Published: (2023-05-01)

Cilostazol protects against degenerative cervical myelopathy injury and cell pyroptosis via TXNIP-NLRP3 pathway
by: Fei Xu, et al.
Published: (2024-01-01)

TXNIP promotes viral replication by disrupting MAVS-mediated antiviral signaling and serves as a therapeutic target for antiviral therapy
by: Ruilin Chen, et al.
Published: (2025-09-01)

Glucose-6-Phosphate Upregulates Txnip Expression by Interacting With MondoA
by: Xueyun Zhang, et al.
Published: (2020-01-01)

TXNIP inhibition in the treatment of type 2 diabetes mellitus: design, synthesis, and biological evaluation of quinazoline derivatives
by: Aiyun Li, et al.
Published: (2023-12-01)

Protein Expression of TXNIP in the Dopaminergic Neurons of Subjects with Parkinson’s Disease: Evidence from a Pilot Study
by: Francesca A. Schillaci, et al.
Published: (2025-08-01)

KLF4 interacts with TXNIP to modulate the pyroptosis in ulcerative colitis via regulating NLRP3 signaling
by: Yuan Chen, et al.
Published: (2024-02-01)

Fluoxetine increases astrocytic glucose uptake and glycolysis in corticosterone-induced depression through restricting GR-TXNIP-GLUT1 Pathway
by: Shu-Man Pan, et al.
Published: (2022-08-01)

Silencing of TXNIP attenuates oxidative stress injury in HEI-OC1 by inhibiting the activation of NLRP3 and NF-κB
by: Ning Ma, et al.
Published: (2024-09-01)

Exercise-induced irisin improves follicular dysfunction by inhibiting IRE1α-TXNIP/ROS-NLRP3 pathway in PCOS
by: Yajing Weng, et al.
Published: (2023-07-01)

Glucose deprivation and identification of TXNIP as an immunometabolic modulator of T cell activation in cancer
by: Agathe Dubuisson, et al.
Published: (2025-04-01)

Verapamil protects against hyperuricemia nephropathy through modulating TXNIP/NLRP3 inflammasome signaling pathway
by: WANG Ting, et al.
Published: (2025-06-01)

TXNIP deficiency attenuates renal fibrosis by modulating mTORC1/TFEB-mediated autophagy in diabetic kidney disease
by: Yunxia Du, et al.
Published: (2024-12-01)

TET2-mediated 5-hydroxymethylcytosine of TXNIP promotes cell cycle arrest in systemic anaplastic large cell lymphoma
by: Ziqing Yu, et al.
Published: (2025-01-01)

Ubiquitin-specific peptidase 25 exacerbated osteoarthritis progression through facilitating TXNIP ubiquitination and NLRP3 inflammasome activation
by: Jie Sui, et al.
Published: (2023-10-01)

TXNIP contributes to induction of pro-inflammatory phenotype and caspase-3 activation in astrocytes during Alzheimer’s diseases
by: Junhyung Kim, et al.
Published: (2023-07-01)

Rubus chingii Hu relieved the polycystic ovary syndrome with enhanced insulin sensitivity through inhibiting TXNIP/NLRP3 inflammasome signaling
by: Huizhen Li, et al.
Published: (2023-12-01)

E3 ubiquitination ligase XIAP lightens diabetes‐induced cognitive impairment by inactivating TXNIP‐ERS‐mediated neuronal injury
by: Qin Zhang, et al.
Published: (2025-01-01)